The Good: Moderna In a world besieged by a pandemic, the best news will always offer remedies for the virus. That’s why Moderna, in announcing that its Covid-19 vaccine is 94% effective, is seeing a milestone day as the news lifts the markets as a whole. Combined with Pfizer’s positive vaccine news from last week, many analysts are seeing the light at the end of the tunnel, and the markets are looking more optimistic. Moderna will apply for emergency use with the Food and Drug Administration within the coming weeks. The company expects to have 20 million doses of the vaccine ready to ship in the US by the end of the year, and plans on rolling out between 500 million and 1 billion doses throughout 2021. Between the two vaccines, there will be 40 million doses, or enough to inoculate 20 million people as the treatment requires two doses. The Bad: Casper Mattress-maker Casper lost some of its bounce today as it released disappointing third quarter results, caused by supply chain issues thanks to the coronavirus. With a net loss of $15.9 million, or 40 cents a share, the stock fell as much as 14% today. Revenue was down 3.3% as direct-to-consumer sales fell amid the closure of its European operations and diminished foot traffic because of lockdown restrictions. This was off-set slightly by a “modest” increase in North American e-commerce sales. Prior to today’s slump, the stock had lost 9.1% of its value over the past three months. The Ugly: Virgin Galactic Just when Virgin Galactic was slated to take off, the commercial spaceflight venture has collided with coronavirus setbacks. As New Mexico seeks to counter their rising caseload, Virgin Galactic has been forced to delay its next spaceflight test due to restrictions. The test was slated to happen between November 19th and 23rd, but is now delayed indefinitely. This test, a vital step in the corporation’s quest to make space travel accessible to consumers, was one of three that was meant to predate the opening of Virgin Galactic’s pedestrian program. Two more regular tests are planned, with a third, which will take the company’s founder, Richard Branson, to space, serving as a showcase of Virgin Galactic’s potential.